MECP2 and Rett syndrome: The findings that interventions targeting excessive ROS in MeCP2-deficient systems and in RTT patients have provided tangible benefits supports the hypothesis that mitochondrial impairments linked to oxidative stress directly contribute to RTT pathogenesis, and are not simply secondary consequences that appear after full symptomatic progression has occurred (Müller and Can, 2014).